312 related articles for article (PubMed ID: 25245607)
21. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
[TBL] [Abstract][Full Text] [Related]
22. Hepatic hemodynamic features in patients with esophageal or gastric varices.
Chao Y; Lin HC; Lee FY; Wang SS; Tsai YT; Hsia HC; Lin WJ; Lee SD; Lo KJ
J Hepatol; 1993 Aug; 19(1):85-9. PubMed ID: 8301048
[TBL] [Abstract][Full Text] [Related]
23. Splanchnic and systemic vasodilatation: the patient.
Tsai MH
J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
[TBL] [Abstract][Full Text] [Related]
24. [Hemodynamic and functional aspects of portal hypertension decompensation in liver cirrhosis].
Kalita NIa; Kotenko OG; Bulanov KI; Furmanenko ED; Egorova OE
Klin Khir (1962); 1994; (11):37-41. PubMed ID: 7658658
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiological-based treatments of complications of cirrhosis.
Møller S; Kimer N; Barløse M; Bendtsen F
Scand J Gastroenterol; 2020 Apr; 55(4):383-394. PubMed ID: 32233873
[TBL] [Abstract][Full Text] [Related]
26. Portal hypertension: pathophysiology, diagnosis and management.
Bloom S; Kemp W; Lubel J
Intern Med J; 2015 Jan; 45(1):16-26. PubMed ID: 25230084
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
28. Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.
Liu H; Gaskari SA; Lee SS
World J Gastroenterol; 2006 Feb; 12(6):837-42. PubMed ID: 16521209
[TBL] [Abstract][Full Text] [Related]
29. The circulation in portal hypertension.
Witte CL; Witte MH
Yale J Biol Med; 1975 May; 48(2):141-55. PubMed ID: 1154812
[No Abstract] [Full Text] [Related]
30. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.
Cirera I; Elizalde JI; Piqué JM; Feu F; Casadevall M; Goldin E; Terés J; Bosch J; Rodés J
Dig Dis Sci; 1997 Aug; 42(8):1697-702. PubMed ID: 9286236
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic alterations in liver cirrhosis.
La Villa G; Gentilini P
Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
[TBL] [Abstract][Full Text] [Related]
32. [Cirrhotic cardiomyopathy: a specific entity].
Brondex A; Arlès F; Lipovac AS; Richecoeur M; Bronstein JA
Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):99-104. PubMed ID: 22115174
[TBL] [Abstract][Full Text] [Related]
33. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
34. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
35. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
Kim MY; Baik SK
Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiology of portal hypertension.
Iwakiri Y
Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
[TBL] [Abstract][Full Text] [Related]
37. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
38. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
[TBL] [Abstract][Full Text] [Related]
39. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
[TBL] [Abstract][Full Text] [Related]
40. Cardiac involvement in liver cirrhosis.
Gatta A; Merkel C; Sacerdoti D; Angeli P
Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
